glp-1 agonists mechanism of action For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH GLP-1 receptor agonists (GLP-1RAs): cardiovascular

Rosenstock J, Ferrannini E

A lower ratio in people who use GLP-1 medications may point to a higher risk of developing NAION, which affects blood flow to the optic nerve

These medications mimic the action of a hormone called glucagon-like peptide-1 (GLP-1), which is naturally released after eating to regulate blood sugar and control appetite

Noteworthy, hyperglycemia induces the synthesis of AT1R, which plays a pivotal role in reno- and cardiovascular disease

demonstrated in KO mice that the regulation of -cell number and function by GLP-1 depends on the cAMP/PKA mediated-induction of insulin-like growth factor-1 receptor (IGF-1R) expression and the increased activity of insulin-like growth factor 2 (IGF-2)/IGF-1R by an autocrine mode of action [25]

Im confident about our natural GLP-1 but I also care about your assessment